Enveric Biosciences, Inc. (ENVB) KPIs and segments

ENVBNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 6/30

$1.52+0.03 (+2.01%)

Close on Nov 12, 2026Market cap $6.80MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Enveric Biosciences's business

Coming soon

This tab will track the numbers specific to Enveric Biosciences's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?